Trial Details

COMPLETED
Basic Information
Clinical ID c4522
Identifier NCT00380250
Trial Title Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Irritable Bowel Syndrome With Constipation
Interventions DRUG: Lubiprostone|DRUG: Placebo
Participant Information
Sponsor Sucampo Pharma Americas, LLC
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2005-05
Primary Completion Date -
Completion Date 2006-07